These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 16582875)

  • 61. [Thiazolidine derivatives].
    Hosoda K
    Nihon Rinsho; 2011 Jan; 69 Suppl 1():636-40. PubMed ID: 21766674
    [No Abstract]   [Full Text] [Related]  

  • 62. [New evidences guide the clinical practice in the prevention and treatment of cardiovascular disease].
    Hu DY
    Zhonghua Yi Xue Za Zhi; 2005 Oct; 85(40):2809-11. PubMed ID: 16324331
    [No Abstract]   [Full Text] [Related]  

  • 63. [Drugs and polypharmacy].
    Alusík S
    Vnitr Lek; 1999 May; 45(5):315-8. PubMed ID: 15641258
    [TBL] [Abstract][Full Text] [Related]  

  • 64. [Current trends in developing anti-obese drugs].
    Fujimoto M; Takemoto M; Yokote K
    Nihon Rinsho; 2011 Jan; 69 Suppl 1():687-91. PubMed ID: 21766682
    [No Abstract]   [Full Text] [Related]  

  • 65. [Therapy of metabolic syndrome].
    Magyar Diabetes Társaság Metabolikus Munkacsoportja
    Orv Hetil; 2003 Jun; 144(23):1145-52. PubMed ID: 12858647
    [No Abstract]   [Full Text] [Related]  

  • 66. [Current status of new drug development for metabolic syndrome].
    Yokode M
    Nihon Rinsho; 2006 Dec; 64 Suppl 9():707-11. PubMed ID: 17458306
    [No Abstract]   [Full Text] [Related]  

  • 67. [Incretin and metabolic syndrome].
    Yamada Y
    Nihon Rinsho; 2011 Jan; 69 Suppl 1():309-13. PubMed ID: 21766615
    [No Abstract]   [Full Text] [Related]  

  • 68. Re: Forgotten risk factors.
    Cary P
    Can J Cardiol; 2005 Nov; 21(13):1225; author reply 1226. PubMed ID: 16389686
    [No Abstract]   [Full Text] [Related]  

  • 69. Maggie's maladies.
    Nazarko L
    Br J Community Nurs; 2011 Jul; 16(7):313. PubMed ID: 21727787
    [No Abstract]   [Full Text] [Related]  

  • 70. [Who is at risk for drug-drug interactions in type 2 diabetic patients?].
    Laurent C; Aho Glele LS; Lazzarotti A; Petit JM; Vergès B; Bouillet B
    Presse Med; 2019 Dec; 48(12):1576-1578. PubMed ID: 31761604
    [No Abstract]   [Full Text] [Related]  

  • 71. [Metabolic syndrome and aging].
    Solano Jaurrieta JJ
    Rev Esp Geriatr Gerontol; 2009; 44(6):335-41. PubMed ID: 19913945
    [TBL] [Abstract][Full Text] [Related]  

  • 72. A lifestyle intervention or metformin prevented or delayed the onset of the metabolic syndrome in persons at risk.
    Sigal RJ
    ACP J Club; 2005; 143(3):67. PubMed ID: 16262224
    [No Abstract]   [Full Text] [Related]  

  • 73. Forget polypharmacy for type 2 diabetes! Weight management is a better investment.
    Lean M; McCombie L; Xin Y
    Nephrol Dial Transplant; 2022 Apr; 37(5):844-846. PubMed ID: 33263751
    [No Abstract]   [Full Text] [Related]  

  • 74. Polypharmacy - is there a cure for drug therapy problems?
    Orehovački H; Brajković A; Bićanić LA; Mucalo I
    Croat Med J; 2023 Aug; 64(4):295-300. PubMed ID: 37654043
    [No Abstract]   [Full Text] [Related]  

  • 75. Polypharmacy: Something more than just numbers.
    Blanco Reina E; Valdellós J
    Med Clin (Barc); 2019 Aug; 153(4):154-156. PubMed ID: 30982532
    [No Abstract]   [Full Text] [Related]  

  • 76. Reply to 'Endpoints in strategies to reduce polypharmacy'.
    Johansson T; Flamm M; Sönnichsen A
    Br J Clin Pharmacol; 2017 Feb; 83(2):434. PubMed ID: 27704600
    [No Abstract]   [Full Text] [Related]  

  • 77. Toothbrushing may reduce risk of metabolic syndrome.
    Saito T
    J Evid Based Dent Pract; 2012 Sep; 12(3):151-3. PubMed ID: 22935283
    [No Abstract]   [Full Text] [Related]  

  • 78. Vacationing More Often May Reduce Metabolic Syndrome Risk.
    Voelker R
    JAMA; 2019 Sep; 322(9):804-805. PubMed ID: 31411646
    [No Abstract]   [Full Text] [Related]  

  • 79. Assessment of Hemoglobin A1c Management and Prescription Cost Due to Polypharmacy Among Patients With Diabetes in Iran Based on the STEPS Iran 2016 Survey and a Prescription Database: A Multi-level, Cross-sectional National Study.
    Daneshmand M; Jamshidi H; Farjoo MH; Malekpour MR; Ghasemi E; Mortazavi SS; Shati M; Farzadfar F
    Arch Iran Med; 2024 Jan; 27(1):1-7. PubMed ID: 38431954
    [TBL] [Abstract][Full Text] [Related]  

  • 80. The Metabolic Syndrome, a Human Disease.
    Alemany M
    Int J Mol Sci; 2024 Feb; 25(4):. PubMed ID: 38396928
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.